Ryan & Maniskas, LLP Announces Investigation of Clinical Data, Inc.

WAYNE, Pa.--(BUSINESS WIRE)--Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/clda) is investigating potential claims against the board of directors of Clinical Data, Inc. ("Clinical Data" or the "Company") (NASDAQ: CLDA) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell Clinical Data to Forest Laboratories, Inc. in a transaction with a value of approximately $1.2 billion.